N95 masks aren’t in shortage anymore, FDA says

The COVID-19 pandemic shoved the nation’s weak supply of personal protective equipment into the limelight when hospitals scrambled to grab enough gowns, medical masks and gloves in 2020. More than two years later, N95 respirator masks exited the FDA’s medical device shortage list.

Advertisement

The decision marks a shift in supply chain resiliency and domestic manufacturing powers, according to the FDA. 

“Today, our national capacity for production of these devices is stronger and our supply chain is more resilient because of these collective efforts on behalf of the dedicated people working to save lives,” Suzanne Schwartz, MD, director of the FDA’s Office of Strategic Partnerships and Technology Innovation, said in an Aug. 26 statement. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.